NASDAQ:GCTK - Nasdaq - US45824Q7051 - Common Stock - Currency: USD
6.62
+0.09 (+1.38%)
The current stock price of GCTK is 6.62 USD. In the past month the price decreased by -23.89%. In the past year, price decreased by -99.69%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.13 | 233.90B | ||
ISRG | INTUITIVE SURGICAL INC | 71.27 | 195.15B | ||
BSX | BOSTON SCIENTIFIC CORP | 38.64 | 154.34B | ||
SYK | STRYKER CORP | 31.55 | 151.06B | ||
MDT | MEDTRONIC PLC | 16.07 | 113.36B | ||
BDX | BECTON DICKINSON AND CO | 12.5 | 50.49B | ||
EW | EDWARDS LIFESCIENCES CORP | 29.53 | 45.05B | ||
IDXX | IDEXX LABORATORIES INC | 47.98 | 44.33B | ||
RMD | RESMED INC | 28.3 | 37.68B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 16.54 | 34.83B | ||
DXCM | DEXCOM INC | 50.26 | 32.52B | ||
STE | STERIS PLC | 25.43 | 23.34B |
GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company is headquartered in Rutherford, New Jersey and currently employs 11 full-time employees. The company went IPO on 2013-04-09. The firm is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. The company has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The firm has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.
GLUCOTRACK INC
301 Rt 17 North, Suite 800
Rutherford NEW JERSEY US
Employees: 6
Phone: 197286757878
The current stock price of GCTK is 6.62 USD. The price increased by 1.38% in the last trading session.
The exchange symbol of GLUCOTRACK INC is GCTK and it is listed on the Nasdaq exchange.
GCTK stock is listed on the Nasdaq exchange.
GLUCOTRACK INC (GCTK) has a market capitalization of 169.41M USD. This makes GCTK a Micro Cap stock.
GLUCOTRACK INC (GCTK) currently has 6 employees.
GLUCOTRACK INC (GCTK) has a resistance level at 8.98. Check the full technical report for a detailed analysis of GCTK support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
GCTK does not pay a dividend.
GLUCOTRACK INC (GCTK) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3287.38).
ChartMill assigns a fundamental rating of 2 / 10 to GCTK. The financial health of GCTK is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months GCTK reported a non-GAAP Earnings per Share(EPS) of -3287.38. The EPS decreased by -46.56% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -275.73% | ||
ROE | -365.16% | ||
Debt/Equity | 0.03 |